One Horizon Group to Present at Oppenheimer 17th Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
One Horizon Group to Present at Oppenheimer 17th Annual Technology, Internet & Communications Conference

BAAR, SWITZERLAND--(Marketwired - Jul 30, 2014) - One Horizon Group, Inc. ( NASDAQ : OHGI ) ("One Horizon" or the "Company"), which develops and licenses the world's most bandwidth efficient mobile voice over Internet Protocol ("VoIP") platform for smart phones, today announced it will attend the Oppenheimer 17th Annual Technology, Internet & Communications Conference at the Four Seasons Hotel in Boston on August 12 and 13, 2014.

One Horizon's Founder and CEO Brian Collins will present on Wednesday, August 13 th . He will also be available for one-on-one meetings on August 12 th and 13 th .

Date: August 13, 2014 Time: 3:45 to 4:20 PM ET Location: Four Seasons Hotel, Boston, MA

Conference participation is by invitation only and registration is required. For more information on the conference or to schedule a one-on-one meeting, please contact an Oppenheimer representative.

About One Horizon Group, Inc. One Horizon Group Inc.'s business is to optimize communications over the Internet through its wholly owned subsidiary, Horizon Globex GmbH, Baar, which develops and markets one of the world's most bandwidth-efficient mobile voice over Internet Protocol (VoIP) platforms for smartphones, and also offers a range of other optimized data applications including messaging and mobile advertising. Horizon Globex GmbH is an ISO 9001 and ISO 20000-1 certified company. The Company has operations in Switzerland, the United Kingdom, China, India, Singapore, Hong Kong and Ireland. For more information on the Company, its products and services, please visit http://www.onehorizongroup.com .

Safe Harbor Statement This news release may contain "forward-looking" statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ from those in the forward looking-statements. Potential risks and uncertainties include such factors as uncertainty of consumer demand for the Company's products, as well as additional risks and uncertainties that are identified and described in Company's SEC reports. Actual results may differ materially from the forward-looking statements in this press release. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company does not undertake, and it specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.

Contact MZ North America Matthew Selinger SVP Tel: +1-949-298-4319 Email Contact www.mzgroup.us

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched for Block Investors This Spring

Updated Category News Views 119

Investigation By Faruqi & Faruqi, LLP Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is currently looking into issues concerning Block, Inc. (NASDAQ: SQ). The firm is focusing on claims related to alleged violations of federal securities laws that may have resulted in significant losses for investors. If you have experienced a loss of over $75,000...

Continue Reading
Aviat Networks Faces Scrutiny After Annual Report Delay

Updated Category News Views 85

Investor Concerns Escalate Amid Aviat Networks' Delay in Reporting Aviat Networks, Inc. (NASDAQ: AVNW) is facing a tough situation as its stock price suffered a notable decline, falling by $6.36, or around 26%, during intraday trading on a recent date. This drop followed the company's announcement that it would miss the deadline for filing its financial statements for the...

Continue Reading
Tarsus Pharmaceuticals Prepares to Share Q2 2025 Results

Updated Category News Views 243

Anticipating Tarsus Pharmaceuticals' Financial Report Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is gearing up to present its financial results for the second quarter of 2025 during a live webcast slated for Wednesday, August 6, 2025. This event will commence at 1:30 p.m. PT and 4:30 p.m. ET, providing a timely update on the company's performance and strategic...

Continue Reading
Country Garden's Stock Recovers After Debt Restructuring Efforts

Updated Category News Views 135

Country Garden’s Stock Trading Resumes with Momentum Recently, shares of Country Garden (HK: 2007), a prominent name in the Chinese property market, saw an impressive rise as trading resumed in Hong Kong after a lengthy suspension of nine months. This rebound came after the company's notable commitment to creating a debt-restructuring plan aimed at appealing to its...

Continue Reading
Unlocking Long-Term Gains: Insights from Dollar Tree's Success

Updated Category News Views 90

Dollar Tree's Remarkable Growth Over Two Decades Over the last 20 years, Dollar Tree (NASDAQ: DLTR) has become a major player in the retail market, demonstrating incredible resilience and expansion. If someone had put $1,000 into Dollar Tree stock two decades ago, that investment would have surged to more than $7,300 today. This change highlights the effectiveness of...

Continue Reading